Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 788–789 | Cite as

ASO Author Reflections: Survival Benefit of Adjuvant Chemoradiotherapy for Gallbladder Cancer: The Role of Radiation Therapy Revisited

  • Byoung Hyuck Kim
  • Eui Kyu ChieEmail author
  • Kyubo KimEmail author
ASO Author Reflections



There are no conflicts of interest.


  1. 1.
    Margonis GA, Gani F, Buettner S, et al. Rates and patterns of recurrence after curative-intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB. 2016;18:872–8.CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Kim BH, Kwon J, Chie EK, et al. Adjuvant chemoradiotherapy is associated with improved survival for patients with resected gallbladder carcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2018;25:255–64.CrossRefGoogle Scholar
  3. 3.
    Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma. Retrieved at: Identifier: NCT02798510. Accessed 18 Sept 2018.
  4. 4.
    Socha J, Michalak M, Wołąkiewicz G, et al. Nodal areas of potential geographic error in adjuvant radiotherapy for biliary tract cancer. Radiother Oncol. 2017;125:365–73.CrossRefGoogle Scholar
  5. 5.
    Primrose JN, Fox R, Palmer DH, et al. Adjuvant capecitabine for biliary tract cancer: the BILCAP randomized study. J Clin Oncol. 2017;35(Suppl). Abstract 4006.Google Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of Radiation OncologySeoul National University College of MedicineSeoulKorea
  2. 2.Institute of Radiation Medicine, Medical Research CenterSeoul National UniversitySeoulKorea
  3. 3.Department of Radiation OncologyEwha Womans University College of MedicineSeoulKorea

Personalised recommendations